HNF1A
Summary: The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
HNF1 homeobox A | MIM:142410 | Ensembl:ENSG00000135100 | HGNC:HGNC:11621 | PA36380 | 12q24.31 |
Gene Categories:
CLINICALLY ACTIONABLEGO terms in HNF1A
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | IBA | GO:0005634 | nucleus |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005737 | cytoplasm |
CC | IDA | GO:0032991 | protein-containing complex |
BP | IDA | GO:0001779 | natural killer cell differentiation |
BP | IBA | GO:0006357 | regulation of transcription by RNA polymerase II |
BP | IDA | GO:0006357 | regulation of transcription by RNA polymerase II |
BP | IEA | GO:0006366 | transcription by RNA polymerase II |
BP | IMP | GO:0035565 | regulation of pronephros size |
BP | IMP | GO:0035623 | renal glucose absorption |
BP | IMP | GO:0042593 | glucose homeostasis |
BP | IBA | GO:0045893 | positive regulation of transcription, DNA-templated |
BP | IDA | GO:0045893 | positive regulation of transcription, DNA-templated |
BP | ISS | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | IMP | GO:0046323 | glucose import |
BP | IGI | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter |
MF | IBA | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding |
MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | ISM | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | NAS | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | ISS | GO:0001077 | transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | IDA | GO:0003677 | DNA binding |
MF | IBA | GO:0003700 | DNA-binding transcription factor activity |
MF | IDA | GO:0003700 | DNA-binding transcription factor activity |
MF | IPI | GO:0005515 | protein binding |
MF | IDA | GO:0044212 | transcription regulatory region DNA binding |
MF | IPI | GO:0046983 | protein dimerization activity |
Gene expression in normal tissue: HNF1A
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in HNF1A
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP236 | Adipogenesis |
wikipathways | WP2877 | Vitamin D Receptor Pathway |
wikipathways | WP3646 | Hepatitis C and Hepatocellular Carcinoma |
wikipathways | WP3893 | Development and heterogeneity of the ILC family |
wikipathways | WP3931 | ESC Pluripotency Pathways |
wikipathways | WP3971 | Role of Osx and miRNAs in tooth development |
pid | hnf3bpathway | FOXA2 and FOXA3 transcription factor networks |
pid | ps1pathway | Presenilin action in Notch and Wnt signaling |
kegg | hsa04550 | Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human) |
kegg | hsa04950 | Maturity onset diabetes of the young - Homo sapiens (human) |
pharmgkb | PA153627758 | Anti-diabetic Drug Potassium Channel Inhibitors Pathway, Pharmacodynamics |
biocarta | ghpathway | growth hormone signaling pathway |
biocarta | malpathway | role of mal in rho-mediated activation of srf |
biocarta | wntpathway | wnt signaling pathway |
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-186712 | Regulation of beta-cell development |
reactome | R-HSA-210745 | Regulation of gene expression in beta cells |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD434 | BMS-536924 | 2 |
iGMDRD105 | Triptolide | 2 |
iGMDRD705 | Nakiterpiosin | 2 |
iGMDRD289 | Parthenolide | 2 |
iGMDRD267 | Oligomycin A | 4 |
iGMDRD137 | Indisulam | 3 |
iGMDRD103 | SN-38 | 4 |
iGMDRD5 | Tyrphostin AG 1478 | 2 |
iGMDRD246 | NPC26 | 2 |
iGMDRD872 | BRD7137 | 2 |
iGMDRD286 | Nsc 632839 | 3 |
iGMDRD366 | PI-103 | 3 |
iGMDRD662 | JQ-1 | 2 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 3 |
iGMDRD116 | CD437 | 1 |
iGMDRD150 | RITA | 4 |
iGMDRD330 | BRD4132 | 2 |
iGMDRD584 | VER 155008 | 2 |
iGMDRD85 | Ursolic acid | 4 |
iGMDRD351 | GW843682X | 5 |
iGMDRD171 | Pemetrexed | 2 |
iGMDRD52 | Rotenone | 4 |
iGMDRD226 | ML006 | 2 |
iGMDRD318 | PAC-1 | 2 |
iGMDRD255 | SB225002 | 3 |
iGMDRD190 | Nilotinib | 1 |
iGMDRD268 | Cerulenin | 1 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD562 | Navitoclax | 3 |
iGMDRD577 | BIX01294 | 2 |
iGMDRD427 | ABT737 | 2 |
iGMDRD494 | Neopeltolide | 2 |
iGMDRD151 | CHM-1 | 2 |
iGMDRD420 | Leucascandrolide A | 4 |
iGMDRD772 | BRD4770 | 3 |
iGMDRD599 | Salermide | 2 |
iGMDRD466 | Chaetocin | 3 |
iGMDRD297 | Austocystin D | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in HNF1A